跳至主要内容
临床试验/TCTR20211203003
TCTR20211203003招募中3 期

Efficacy of Microneedle Fractional Radiofrequency combined with Topical Insulin for the treatment of facial atrophic acne scar: A split-face, double-blinded, randomized, placebo-controlled trial

Division of Dermatology, Ramathibodi Hospital, Mahidol University0 个研究点目标入组 60 人开始时间: 2021年12月3日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • 1. No serious underlying conditions
  • 2. Symmetrical facial acne scar
  • 3. Agree to participate and signed informed consent form

排除标准

  • 1. History of infection at facial area
  • 2. Uncontrolled acne vulgaris
  • 3. History of keloid scar or hypertrophic scar
  • 4. Immunocompromised host
  • 5. History of dermatological malignancy
  • 6. History of herpes infection
  • 7. History of using vitamin A derivatives within 3 months
  • 8. History of laser treatment within 3 months
  • 9. History of chemical peeling within 3 months
  • 10. Underlying diabetes mellitus, connective tissue diseases, and photodermatoses
  • 11. Allergic to insulin and topical anesthesic drugs
  • 12. Pregnancy or lactation

研究者

发起方
Division of Dermatology, Ramathibodi Hospital, Mahidol University

相似试验

Efficacy of Microneedle Fractional Radiofrequency... | 临床试验